Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Sci Rep ; 7: 44416, 2017 03 15.
Article in English | MEDLINE | ID: mdl-28294142

ABSTRACT

Neurogenic detrusor overactivity (NDO) is among the most challenging complications of spinal cord injury (SCI). A recent report by us demonstrated an improvement in NDO in SCI rats following chronic systemic treatment with the purine nucleoside inosine. The objective of this study was to investigate the mechanism of action of inosine underlying improvement of NDO. Male Sprague-Dawley rats underwent complete spinal cord transection at T8. Inosine (1 mM) delivered intravesically to SCI rats during conscious cystometry significantly decreased the frequency of spontaneous non-voiding contractions. In isolated tissue assays, inosine (1 mM) significantly decreased the amplitude of spontaneous activity (SA) in SCI bladder muscle strips. This effect was prevented by a pan-adenosine receptor antagonist CGS15943, but not by A1 or A3 receptor antagonists. The A2A antagonist ZM241385 and A2B antagonist PSB603 prevented the effect of inosine. The effect of inosine was mimicked by the adenosine receptor agonist NECA and the A2B receptor agonist BAY60-6583. The inhibition of SA by inosine was not observed in the presence of the BK antagonist, iberiotoxin, but persisted in the presence of KATP and SK antagonists. These findings demonstrate that inosine acts via an A2B receptor-mediated pathway that impinges on specific potassium channel effectors.


Subject(s)
Inosine/administration & dosage , Receptor, Adenosine A2A/genetics , Spinal Cord Injuries/drug therapy , Urinary Bladder, Neurogenic/drug therapy , Adenosine A2 Receptor Antagonists/administration & dosage , Animals , Disease Models, Animal , Humans , Potassium Channels/genetics , Rats , Spinal Cord Injuries/complications , Spinal Cord Injuries/genetics , Spinal Cord Injuries/physiopathology , Sulfonamides/administration & dosage , Triazines/administration & dosage , Triazoles/administration & dosage , Urinary Bladder, Neurogenic/etiology , Urinary Bladder, Neurogenic/genetics , Urinary Bladder, Neurogenic/physiopathology , Urinary Bladder, Overactive/drug therapy , Urinary Bladder, Overactive/etiology , Urinary Bladder, Overactive/genetics , Urinary Bladder, Overactive/physiopathology , Xanthines/administration & dosage
2.
JCI Insight ; 2(3): e90617, 2017 02 09.
Article in English | MEDLINE | ID: mdl-28194441

ABSTRACT

Chronic urethral obstruction and the ensuing bladder wall remodeling can lead to diminished bladder smooth muscle (BSM) contractility and debilitating lower urinary tract symptoms. No effective pharmacotherapy exists to restore BSM contractile function. Neuropilin 2 (Nrp2) is a transmembrane protein that is highly expressed in BSM. Nrp2 deletion in mice leads to increased BSM contraction. We determined whether genetic ablation of Nrp2 could restore BSM contractility following obstruction. Partial bladder outlet obstruction (pBOO) was created by urethral occlusion in mice with either constitutive and ubiquitous, or inducible smooth muscle-specific deletion of Nrp2, and Nrp2-intact littermates. Mice without obstruction served as additional controls. Contractility was measured by isometric tension testing. Nrp2 deletion prior to pBOO increased force generation in BSM 4 weeks following surgery. Deletion of Nrp2 in mice already subjected to pBOO for 4 weeks showed increased contractility of tissues tested 6 weeks after surgery compared with nondeleted controls. Assessment of tissues from patients with urodynamically defined bladder outlet obstruction revealed reduced NRP2 levels in obstructed bladders with compensated compared with decompensated function, relative to asymptomatic controls. We conclude that downregulation of Nrp2 promotes BSM force generation. Neuropilin 2 may represent a novel target to restore contractility following obstruction.


Subject(s)
Gene Knockout Techniques/methods , Neuropilin-2/genetics , Urinary Bladder Neck Obstruction/therapy , Urinary Bladder/physiology , Animals , Disease Models, Animal , Humans , Isometric Contraction , Male , Mice , Urinary Bladder Neck Obstruction/etiology , Urinary Bladder Neck Obstruction/genetics , Urinary Bladder Neck Obstruction/physiopathology , Urodynamics
3.
PLoS One ; 10(11): e0142329, 2015.
Article in English | MEDLINE | ID: mdl-26544690

ABSTRACT

Merkel cell polyomavirus (MCV) causes the majority of human Merkel cell carcinomas (MCC) and encodes a small T (sT) antigen that transforms immortalized rodent fibroblasts in vitro. To develop a mouse model for MCV sT-induced carcinogenesis, we generated transgenic mice with a flox-stop-flox MCV sT sequence homologously recombined at the ROSA locus (ROSAsT), allowing Cre-mediated, conditional MCV sT expression. Standard tamoxifen (TMX) administration to adult UbcCreERT2; ROSAsT mice, in which Cre is ubiquitously expressed, resulted in MCV sT expression in multiple organs that was uniformly lethal within 5 days. Conversely, most adult UbcCreERT2; ROSAsT mice survived low-dose tamoxifen administration but developed ear lobe dermal hyperkeratosis and hypergranulosis. Simultaneous MCV sT expression and conditional homozygous p53 deletion generated multi-focal, poorly-differentiated, highly anaplastic tumors in the spleens and livers of mice after 60 days of TMX treatment. Mouse embryonic fibroblasts from these mice induced to express MCV sT exhibited anchorage-independent cell growth. To examine Merkel cell pathology, MCV sT expression was also induced during mid-embryogenesis in Merkel cells of Atoh1CreERT2/+; ROSAsT mice, which lead to significantly increased Merkel cell numbers in touch domes at late embryonic ages that normalized postnatally. Tamoxifen administration to adult Atoh1CreERT2/+; ROSAsT and Atoh1CreERT2/+; ROSAsT; p53flox/flox mice had no effects on Merkel cell numbers and did not induce tumor formation. Taken together, these results show that MCV sT stimulates progenitor Merkel cell proliferation in embryonic mice and is a bona fide viral oncoprotein that induces full cancer cell transformation in the p53-null setting.


Subject(s)
Antigens, Viral, Tumor/genetics , Carcinoma, Merkel Cell/pathology , Cell Transformation, Viral , Embryo, Mammalian/pathology , Merkel Cells/pathology , Merkel cell polyomavirus/physiology , Skin Neoplasms/pathology , Anaplasia , Animals , Carcinoma, Merkel Cell/virology , Cell Count , Cell Differentiation , Cell Line, Tumor , Cell Proliferation , Disease Models, Animal , Female , Humans , Liver/pathology , Male , Merkel cell polyomavirus/immunology , Mice , Mice, Inbred C57BL , Mice, Transgenic , Pregnancy , Skin Neoplasms/virology , Spleen/pathology , Tumor Suppressor Protein p53/deficiency , Tumor Suppressor Protein p53/genetics
4.
Mol Biol Cell ; 24(7): 1007-19, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23389633

ABSTRACT

Multiple Rabs are associated with secretory granules/vesicles, but how these GTPases are coordinated to promote regulated exocytosis is not well understood. In bladder umbrella cells a subapical pool of discoidal/fusiform-shaped vesicles (DFVs) undergoes Rab11a-dependent regulated exocytosis in response to bladder filling. We show that Rab11a-associated vesicles are enmeshed in an apical cytokeratin meshwork and that Rab11a likely acts upstream of Rab8a to promote exocytosis. Surprisingly, expression of Rabin8, a previously described Rab11a effector and guanine nucleotide exchange factor for Rab8, stimulates stretch-induced exocytosis in a manner that is independent of its catalytic activity. Additional studies demonstrate that the unconventional motor protein myosin5B motor (Myo5B) works in association with the Rab8a-Rab11a module to promote exocytosis, possibly by ensuring transit of DFVs through a subapical, cortical actin cytoskeleton before fusion. Our results indicate that Rab11a, Rab8a, and Myo5B function as part of a network to promote stretch-induced exocytosis, and we predict that similarly organized Rab networks will be common to other regulated secretory pathways.


Subject(s)
Exocytosis , Myosins/metabolism , Urinary Bladder/metabolism , rab GTP-Binding Proteins/metabolism , Actin Cytoskeleton/metabolism , Animals , Female , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , Human Growth Hormone/genetics , Human Growth Hormone/metabolism , Humans , Microscopy, Confocal , Microscopy, Electron , Myosins/genetics , Rats , Rats, Sprague-Dawley , Signal Transduction , Stress, Mechanical , Urinary Bladder/cytology , Urinary Bladder/ultrastructure , rab GTP-Binding Proteins/genetics
5.
PLoS One ; 7(7): e41816, 2012.
Article in English | MEDLINE | ID: mdl-22848617

ABSTRACT

Uroplakin (UP)3a is critical for urinary tract development and function; however, its role in these processes is unknown. We examined the function of the UP3a-like protein Upk3l, which was expressed at the apical surfaces of the epithelial cells that line the pronephric tubules (PTs) of the zebrafish pronephros. Embryos treated with upk3l-targeted morpholinos showed decreased pronephros function, which was attributed to defects in PT epithelial cell morphogenesis and polarization including: loss of an apical brush border and associated phospho-ERM proteins, apical redistribution of the basolateral Na(+)/K(+)-ATPase, and altered or diminished expression of the apical polarity complex proteins Prkcz (atypical protein kinase C zeta) and Pard3 (Par3). Upk3l missing its C-terminal cytoplasmic domain or containing mutations in conserved tyrosine or proline residues did not rescue, or only partially rescued the effects of Upk3l depletion. Our studies indicate that Upk3l promotes epithelial polarization and morphogenesis, likely by forming or stimulating interactions with cytoplasmic signaling or polarity proteins, and that defects in this process may underlie the pathology observed in UP3a knockout mice or patients with renal abnormalities that result from altered UP3a expression.


Subject(s)
Cell Polarity , Epithelial Cells/cytology , Kidney Tubules/cytology , Kidney Tubules/growth & development , Morphogenesis , Uroplakin III/metabolism , Zebrafish Proteins/metabolism , Zebrafish/growth & development , Amino Acid Sequence , Animals , Dogs , Edema, Cardiac/genetics , Epithelial Cells/metabolism , Gene Expression Regulation , Gene Knockdown Techniques , Humans , Kidney/abnormalities , Kidney Tubules/physiology , Kidney Tubules/physiopathology , Mice , Molecular Sequence Data , Mutation , Protein Structure, Tertiary , Rats , Urogenital Abnormalities/genetics , Uroplakin III/chemistry , Uroplakin III/deficiency , Uroplakin III/genetics , Zebrafish/metabolism , Zebrafish Proteins/chemistry , Zebrafish Proteins/deficiency , Zebrafish Proteins/genetics
6.
Proc Natl Acad Sci U S A ; 108(23): 9703-8, 2011 Jun 07.
Article in English | MEDLINE | ID: mdl-21606375

ABSTRACT

During early development, midbrain dopaminergic (mDA) neuronal progenitors (NPs) arise from the ventral mesencephalic area by the combined actions of secreted factors and their downstream transcription factors. These mDA NPs proliferate, migrate to their final destinations, and develop into mature mDA neurons in the substantia nigra and the ventral tegmental area. Here, we show that such authentic mDA NPs can be efficiently isolated from differentiated ES cells (ESCs) using a FACS method combining two markers, Otx2 and Corin. Purified Otx2(+)Corin(+) cells coexpressed other mDA NP markers, including FoxA2, Lmx1b, and Glast. Using optimized culture conditions, these mDA NPs continuously proliferated up to 4 wk with almost 1,000-fold expansion without significant changes in their phenotype. Furthermore, upon differentiation, Otx2(+)Corin(+) cells efficiently generated mDA neurons, as evidenced by coexpression of mDA neuronal markers (e.g., TH, Pitx3, Nurr1, and Lmx1b) and physiological functions (e.g., efficient DA secretion and uptake). Notably, these mDA NPs differentiated into a relatively homogenous DA population with few serotonergic neurons. When transplanted into PD model animals, aphakia mice, and 6-OHDA-lesioned rats, mDA NPs differentiated into mDA neurons in vivo and generated well-integrated DA grafts, resulting in significant improvement in motor dysfunctions without tumor formation. Furthermore, grafted Otx2(+)Corin(+) cells exhibited significant migratory function in the host striatum, reaching >3.3 mm length in the entire striatum. We propose that functional and expandable mDA NPs can be efficiently isolated by this unique strategy and will serve as useful tools in regenerative medicine, bioassay, and drug screening.


Subject(s)
Cell Differentiation , Embryonic Stem Cells/cytology , Mesencephalon/cytology , Neural Stem Cells/cytology , Animals , Cell Line , Cell Proliferation , Dopamine/metabolism , Embryonic Stem Cells/metabolism , Fibroblast Growth Factor 2/pharmacology , Fibroblast Growth Factor 8/pharmacology , Flow Cytometry , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , Immunohistochemistry , Male , Mesencephalon/metabolism , Mice , Mice, Inbred C57BL , Microscopy, Fluorescence , Motor Activity , Neural Stem Cells/drug effects , Neural Stem Cells/metabolism , Otx Transcription Factors/genetics , Otx Transcription Factors/metabolism , Oxidopamine , Parkinson Disease, Secondary/chemically induced , Parkinson Disease, Secondary/physiopathology , Parkinson Disease, Secondary/surgery , Rats , Rats, Sprague-Dawley , Serine Endopeptidases/genetics , Serine Endopeptidases/metabolism , Stem Cell Transplantation/methods
SELECTION OF CITATIONS
SEARCH DETAIL
...